WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareMedical Instruments & Supplies
Best Medical Stocks to Buy Now (2024)
Top medical stocks in 2024 ranked by overall Zen Score. See the best medical stocks to buy now, according to analyst forecasts for the medical instruments & supplies industry.

Industry: Medical Instruments & Sup...
Ticker
Company
Country
Market Cap
Shares
Institutional %
Insider %
Net Insider (L12M)
Net Insider (L3M)
RMD
RESMED INC
United States
$30.09B146,907,20755.32%4.26%Net SellingNet Selling
WST
WEST PHARMACEUTICAL SERVICES INC
United States
$23.53B72,843,15792.82%3.68%Net BuyingNet Buying
UTMD
UTAH MEDICAL PRODUCTS INC
United States
$242.16M3,528,42664.71%35.29%Net SellingNet Selling
LMAT
LEMAITRE VASCULAR INC
United States
$1.93B22,446,10974.73%25.27%Net SellingNet Selling
ALC
ALCON INC
United States
$45.36B494,400,00047.40%0.00%
ATR
APTARGROUP INC
United States
$9.58B66,263,63188.35%3.66%Net SellingNet Selling
ISRG
INTUITIVE SURGICAL INC
United States
$157.55B354,705,82283.20%0.81%Net BuyingNet Selling
BDX
BECTON DICKINSON & CO
United States
$66.21B289,006,46184.44%0.63%Net SellingNet Selling
OSUR
ORASURE TECHNOLOGIES INC
United States
$318.02M73,959,28992.03%7.97%Net SellingNet Selling
COO
COOPER COMPANIES INC
United States
$18.08B199,119,88093.32%0.86%Net Selling
MMSI
MERIT MEDICAL SYSTEMS INC
United States
$5.02B58,105,65494.95%5.05%Net BuyingNet Buying
HAE
HAEMONETICS CORP
United States
$4.61B50,841,44297.24%2.76%Net SellingNet Selling
HOLX
HOLOGIC INC
United States
$18.13B233,376,94886.52%13.48%Net SellingNet Selling
TFX
TELEFLEX INC
United States
$10.38B47,102,56294.39%2.72%Net Selling
NEPH
NEPHROS INC
United States
$24.15M10,544,1395.53%94.47%Net BuyingNet Buying
ATRI
ATRION CORP
United States
$801.84M1,759,95458.60%41.40%Net BuyingNet Selling
ATRC
ATRICURE INC
United States
$1.12B48,382,32576.00%24.00%Net SellingNet Buying
STAA
STAAR SURGICAL CO
United States
$2.31B49,131,11061.27%38.73%Net BuyingNet Selling
RGEN
REPLIGEN CORP
United States
$7.04B55,875,89472.70%27.30%Net SellingNet Selling
MHUA
MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES CO LTD
China
$22.38M23,940,0001.90%0.00%
NYXH
NYXOAH SA
Belgium
$270.76M28,682,6357.60%0.00%
PDEX
PRO DEX INC
United States
$60.76M3,419,0895.96%94.04%Net SellingNet Selling
STVN
STEVANATO GROUP SPA
Italy
$6.42B295,540,03617.31%0.00%
BAX
BAXTER INTERNATIONAL INC
United States
$18.00B509,580,19084.53%15.47%Net SellingNet Selling
XRAY
DENTSPLY SIRONA INC
United States
$5.30B207,630,55697.74%2.26%Net SellingNet Selling
AKYA
AKOYA BIOSCIENCES INC
United States
$114.08M49,386,24730.08%51.98%Net SellingNet Buying
ZJYL
JIN MEDICAL INTERNATIONAL LTD
China
$454.40M160,000,0000.49%0.00%
FEMY
FEMASYS INC
United States
$25.33M22,220,7186.63%8.01%
EMBC
EMBECTA CORP
United States
$759.52M57,670,20995.80%1.52%Net SellingNet Selling
SMTI
SANARA MEDTECH INC
United States
$249.10M8,625,2010.53%99.47%Net Selling
EKSO
EKSO BIONICS HOLDINGS INC
United States
$21.63M18,174,4265.55%94.45%Net Selling
BLFS
BIOLIFE SOLUTIONS INC
United States
$953.76M46,030,88658.37%41.63%Net BuyingNet Selling
LUCY
INNOVATIVE EYEWEAR INC
United States
$7.32M17,501,0661.02%28.12%
WRBY
WARBY PARKER INC
United States
$1.92B118,862,32750.24%49.76%Net SellingNet Selling
OMIC
SINGULAR GENOMICS SYSTEMS INC
United States
$21.59M2,469,76647.25%52.75%Net Selling
BNGO
BIONANO GENOMICS INC
United States
$43.72M66,856,8047.34%38.79%Net Selling
NXGL
NEXGEL INC
United States
$13.45M6,227,6242.42%31.25%Net Buying
HBIO
HARVARD BIOSCIENCE INC
United States
$141.58M43,429,62650.84%49.16%Net SellingNet Buying
KRMD
KORU MEDICAL SYSTEMS INC
United States
$121.28M45,764,22540.98%49.32%Net BuyingNet Buying
MLSS
MILESTONE SCIENTIFIC INC
United States
$78.00M77,227,7145.41%57.13%Net BuyingNet Buying
AZTA
AZENTA INC
United States
$2.89B53,918,93481.77%18.23%Net SellingNet Selling
MBOT
MICROBOT MEDICAL INC
United States
$15.55M14,398,9644.35%95.65%
INFU
INFUSYSTEM HOLDINGS INC
United States
$146.94M21,295,25426.49%73.51%Net SellingNet Buying
ICUI
ICU MEDICAL INC
United States
$3.07B24,365,99069.08%30.92%Net SellingNet Selling
POAI
PREDICTIVE ONCOLOGY INC
United States
$4.59M4,101,7760.16%99.84%Net Selling
BLCO
BAUSCH & LOMB CORP
Canada
$5.60B351,482,10010.68%88.95%Net SellingNet Selling
POCI
PRECISION OPTICS CORPORATION INC
United States
$37.56M6,068,5189.37%90.63%
ZTEK
ZENTEK LTD
Canada
$97.79M100,819,5770.93%0.00%
PLSE
PULSE BIOSCIENCES INC
United States
$1.03B55,225,3338.61%89.75%Net BuyingNet Buying
STXS
STEREOTAXIS INC
United States
$157.02M82,643,24327.28%72.72%Net BuyingNet Buying
RVP
RETRACTABLE TECHNOLOGIES INC
United States
$35.63M29,937,1596.55%93.45%Net BuyingNet Buying
AVGR
AVINGER INC
United States
$2.86M1,702,2261.21%98.79%Net Selling
NVST
ENVISTA HOLDINGS CORP
United States
$2.76B171,858,24563.09%36.91%Net SellingNet Selling
ANGO
ANGIODYNAMICS INC
United States
$240.33M40,054,53379.66%20.34%Net Selling
GCTK
GLUCOTRACK INC
United States
$9.15M5,478,60014.32%61.42%Net BuyingNet Buying
STSS
SHARPS TECHNOLOGY INC
United States
$4.17M15,670,8987.40%23.64%Net Buying

Medical Stocks FAQ

What are the best medical stocks to buy right now in Jul 2024?

According to Zen Score, the 3 best medical stocks to buy right now are:

1. Resmed (NYSE:RMD)


Resmed (NYSE:RMD) is the top medical stock with a Zen Score of 57, which is 28 points higher than the medical industry average of 29. It passed 22 out of 38 due diligence checks and has strong fundamentals. Resmed has seen its stock lose -5.56% over the past year, overperforming other medical stocks by 3 percentage points.

Resmed has an average 1 year price target of $211.50, an upside of 3.26% from Resmed's current stock price of $204.83.

Resmed stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Resmed, 33.33% have issued a Strong Buy rating, 33.33% have issued a Buy, 33.33% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. West Pharmaceutical Services (NYSE:WST)


West Pharmaceutical Services (NYSE:WST) is the second best medical stock with a Zen Score of 54, which is 25 points higher than the medical industry average of 29. It passed 20 out of 38 due diligence checks and has strong fundamentals. West Pharmaceutical Services has seen its stock lose -15.79% over the past year, underperforming other medical stocks by -7 percentage points.

West Pharmaceutical Services has an average 1 year price target of $460.33, an upside of 42.53% from West Pharmaceutical Services's current stock price of $322.98.

West Pharmaceutical Services stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering West Pharmaceutical Services, 66.67% have issued a Strong Buy rating, 0% have issued a Buy, 33.33% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Utah Medical Products (NASDAQ:UTMD)


Utah Medical Products (NASDAQ:UTMD) is the third best medical stock with a Zen Score of 50, which is 21 points higher than the medical industry average of 29. It passed 17 out of 38 due diligence checks and has strong fundamentals. Utah Medical Products has seen its stock lose -27% over the past year, underperforming other medical stocks by -18 percentage points.

What are the medical stocks with highest dividends?

Out of 10 medical stocks that have issued dividends in the past year, the 3 medical stocks with the highest dividend yields are:

1. Dentsply Sirona (NASDAQ:XRAY)


Dentsply Sirona (NASDAQ:XRAY) has an annual dividend yield of 2.35%, which is 1 percentage points higher than the medical industry average of 1.24%. Dentsply Sirona's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Dentsply Sirona's dividend has shown consistent growth over the last 10 years.

Dentsply Sirona's dividend payout ratio of -134.9% indicates that its dividend yield might not be sustainable for the long-term.

2. Atrion (NASDAQ:ATRI)


Atrion (NASDAQ:ATRI) has an annual dividend yield of 1.93%, which is 1 percentage points higher than the medical industry average of 1.24%. Atrion's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Atrion's dividend has shown consistent growth over the last 10 years.

Atrion's dividend payout ratio of 82.3% indicates that its dividend yield is sustainable for the long-term.

3. Utah Medical Products (NASDAQ:UTMD)


Utah Medical Products (NASDAQ:UTMD) has an annual dividend yield of 1.74%, which is the same as the medical industry average of 1.24%. Utah Medical Products's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Utah Medical Products's dividend has shown consistent growth over the last 10 years.

Utah Medical Products's dividend payout ratio of 26.4% indicates that its dividend yield is sustainable for the long-term.

Why are medical stocks up?

Medical stocks were up 0.26% in the last day, and up 2.72% over the last week.

We couldn't find a catalyst for why medical stocks are up.

What are the most undervalued medical stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued medical stocks right now are:

1. Utah Medical Products (NASDAQ:UTMD)


Utah Medical Products (NASDAQ:UTMD) is the most undervalued medical stock based on WallStreetZen's Valuation Score. Utah Medical Products has a valuation score of 71, which is 53 points higher than the medical industry average of 18. It passed 5 out of 7 valuation due diligence checks.

Utah Medical Products's stock has dropped -27% in the past year. It has underperformed other stocks in the medical industry by -18 percentage points.

2. Embecta (NASDAQ:EMBC)


Embecta (NASDAQ:EMBC) is the second most undervalued medical stock based on WallStreetZen's Valuation Score. Embecta has a valuation score of 57, which is 39 points higher than the medical industry average of 18. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has dropped -34.9% in the past year. It has underperformed other stocks in the medical industry by -26 percentage points.

3. Meihua International Medical Technologies Co (NASDAQ:MHUA)


Meihua International Medical Technologies Co (NASDAQ:MHUA) is the third most undervalued medical stock based on WallStreetZen's Valuation Score. Meihua International Medical Technologies Co has a valuation score of 43, which is 25 points higher than the medical industry average of 18. It passed 3 out of 7 valuation due diligence checks.

Meihua International Medical Technologies Co's stock has dropped -62.75% in the past year. It has underperformed other stocks in the medical industry by -54 percentage points.

Are medical stocks a good buy now?

52.5% of medical stocks rated by analysts are a strong buy right now. On average, analysts expect medical stocks to rise by 20.19% over the next year.

What is the average p/e ratio of the medical instruments & supplies industry?

The average P/E ratio of the medical instruments & supplies industry is 56.61x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.